H.R. 6238 · 116th Congress

Cameron’s Law

Stage
In committee
Introduced
2020-03-12
Latest action
2020-03-12 · Introduced in House

Summary

Cameron's Law

This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit).

The bill also requires the Centers for Disease Control and Prevention to complete a study and report on enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.